Trials / Completed
CompletedNCT02856542
Real-life Evaluation of the Daivobet® Gel Applicator
Real-life Evaluation of an Applicator, as a New Mode of Administration of Daivobet® Gel, on Adherence to Treatment and SAtisfaction of Patients With PSOriasis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,560 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to describe the patient population being treated and evaluate their treatment adherence and treatment outcomes during treatment of scalp psoriasis with Daivobet® gel Applicator for 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | calcipotriol/betamethasone dipropionate gel in Applicator | Topical treatment of scalp using applicator device. The study as such is non-interventional as the intervention has been decided prior to and independently from the inclusion of the patient in the cohort to be observed. |
Timeline
- Start date
- 2016-05-23
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-08-05
- Last updated
- 2017-10-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02856542. Inclusion in this directory is not an endorsement.